◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
丸美生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013FY 2012Dec 31, 2012FY 2011Dec 31, 2011
+Revenue 3.0B 2.2B 1.7B 1.8B 1.7B 1.8B 1.6B 1.4B 1.2B 1.2B 1.1B 974.0M 815.0M 613.0M
Revenue Growth % 33.4% 28.5% -3.1% 2.4% -3.1% 14.3% 16.6% 11.9% 1.4% 10.7% 10.5% 19.5% 33.0% --
Total Revenue 3.0B 2.2B 1.7B 1.8B 1.7B 1.8B 1.6B 1.4B 1.2B 1.2B 1.1B 974.0M 815.0M 613.0M
Cost Of Revenue 781.0M 652.0M 547.0M 643.0M 590.0M 573.0M 499.0M 429.0M 391.0M 373.0M 270.0M 232.0M 207.0M 132.0M
+Gross Profit 2.2B 1.6B 1.2B 1.1B 1.2B 1.2B 1.1B 923.0M 817.0M 818.0M 806.0M 742.0M 608.0M 481.0M
Gross Margin % 73.7% 70.7% 68.4% 64.0% 66.2% 68.2% 68.3% 68.3% 67.6% 68.7% 74.9% 76.2% 74.6% 78.5%
Total Operating Cost 2.6B 2.0B 1.6B 1.5B 1.2B 1.3B 1.2B 1.0B 948.0M 877.0M 769.0M 724.0M 602.0M 414.0M
Selling Expenses 1.6B 1.2B 846.0M 741.0M 564.0M 540.0M 535.0M 467.0M 472.0M 420.0M 405.0M 423.0M 346.0M 240.0M
Admin Expenses 109.0M 109.0M 111.0M 100.0M 78.6M 90.6M 72.5M 67.9M 56.5M 84.3M 87.2M 60.9M 41.9M 32.5M
Rd Expenses 73.5M 62.3M 52.9M 50.5M 50.2M 44.9M 33.8M 28.3M 24.8M -- -- -- -- --
Finance Expenses -14.1M -14.4M -12.6M -35.8M -57.3M -22.4M -7.4M -12.3M -16.4M -15.5M -7.1M -5.4M -3.6M -1.1M
+Operating Income 381.0M 319.0M 207.0M 299.0M 573.0M 613.0M 484.0M 366.0M 260.0M 314.0M 306.0M 250.0M 213.0M 201.0M
Operating Margin % 12.8% 14.3% 12.0% 16.7% 32.8% 34.0% 30.7% 27.1% 21.5% 26.4% 28.4% 25.7% 26.1% 32.8%
Non Operating Income 325,600 242,600 486,600 12.2M 226,500 2.2M 2.4M 830,200 13.8M 18.1M 13.3M 11.8M 8.4M 19,000
Non Operating Expenses 605,900 2.5M 1.2M 1.6M 5.4M 806,000 256,400 240,600 600,200 1.8M 642,900 3.3M 582,000 1.6M
Investment Income 20.0M 43.6M 27.5M 24.7M 36.2M 26.9M 25.1M 12.4M -- -- -- -- -- 1.9M
Fair Value Change Income -982,900 71.0M 5.3M 611,100 -2.6M 6.1M -- -- -- -- -- -- -- --
Asset Disposal Income 29,600 514,600 308,800 421,600 -- -- -200.00 -200.00 -72,700 -111,900 -- -- -- --
Asset Impairment Loss 12.2M 13.1M 9.8M 11.5M 5.9M 14.0M 3.1M 6.9M 1.7M 37,200 -17,300 123,600 110,600 -126,300
Other Income 14.4M 19.3M 24.1M 21.9M 43.6M 40.4M 39.8M 5.4M -- -- -- -- -- --
Income Before Tax 381.0M 317.0M 207.0M 310.0M 567.0M 614.0M 486.0M 367.0M 274.0M 330.0M 319.0M 258.0M 221.0M 200.0M
Income Tax 38.3M 39.5M 39.2M 68.4M 104.0M 101.0M 74.3M 54.7M 41.3M 48.6M 47.4M 39.7M 33.8M 32.6M
+Net Income 342.0M 278.0M 167.0M 241.0M 463.0M 513.0M 412.0M 312.0M 232.0M 281.0M 271.0M 219.0M 187.0M 167.0M
Net Margin % 11.5% 12.5% 9.6% 13.5% 26.5% 28.5% 26.1% 23.1% 19.2% 23.6% 25.2% 22.5% 22.9% 27.2%
Net Income Attributable 342.0M 259.0M 174.0M 248.0M 464.0M 515.0M 415.0M 312.0M 232.0M 281.0M 271.0M 219.0M 187.0M 167.0M
Minority Interest 735,200 18.2M -6.8M -6.7M -1.0M -2.1M -3.2M -- -- -- -- -- -19,300 --
Eps Basic 0.85 0.65 0.43 0.62 1.16 1.37 1.15 0.87 0.64 0.78 0.75 0.61 1.04 --
Eps Diluted 0.85 0.65 0.43 0.62 1.16 1.37 1.15 0.87 0.64 0.78 0.75 0.61 1.04 --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013FY 2012Dec 31, 2012FY 2011Dec 31, 2011
Cash And Equivalents 2.0B 1.1B 1.1B 806.0M 1.7B 2.1B 1.6B 1.1B 941.0M 850.0M 757.0M 545.0M 387.0M 364.0M
Trading Financial Assets 396.0M 768.0M 438.0M 738.0M 821.0M 796.0M -- -- -- -- -- -- -- --
Accounts Receivable 45.0M 28.0M 69.8M 57.4M 5.2M 1.8M 2.9M 9.2M 29.3M 2.7M 4.9M 5.9M 3.3M 1.9M
Notes Receivable -- 3.5M 4.1M 5.5M -- -- -- -- 20.6M 15.6M -- -- -- --
Notes And Accounts Receivable 45.0M 31.5M 73.9M 62.8M 5.2M 1.8M 2.9M 9.2M 49.9M 18.3M 4.9M 5.9M 3.3M 1.9M
Prepayments 41.4M 24.7M 18.7M 35.8M 32.5M 21.2M 17.2M 13.7M 12.0M 9.5M 889,200 6.3M 23.4M 30.9M
Inventory 220.0M 172.0M 152.0M 138.0M 138.0M 187.0M 129.0M 113.0M 107.0M 116.0M 74.8M 85.3M 64.7M 43.4M
Total Current Assets 3.0B 2.5B 2.2B 2.0B 2.7B 3.1B 1.8B 1.3B 1.1B 1.0B 848.0M 650.0M 484.0M 443.0M
Long Term Equity Investment 166.0M 63.6M 73.9M 75.1M 49.9M -- -- -- -- -- -- -- -- --
Fixed Assets 476.0M 454.0M 249.0M 247.0M 244.0M 249.0M 260.0M -- -- 287.0M 289.0M 179.0M 12.1M 3.4M
Fixed Assets Total 476.0M 454.0M 249.0M 247.0M 244.0M 249.0M 260.0M 263.0M 279.0M 287.0M 289.0M 179.0M 12.1M 3.4M
Construction In Progress 603.0M 309.0M 253.0M 119.0M 2.0M -- 191,600 -- -- 1.4M 3.5M 76.2M 172.0M 21.7M
Construction In Progress Total 603.0M 309.0M 253.0M 119.0M 2.0M -- 191,600 1.3M 1.3M 1.4M 3.5M 76.2M 172.0M 21.7M
Intangible Assets 699.0M 720.0M 749.0M 765.0M 18.6M 17.7M 27.6M 17.8M 17.4M 13.8M 12.3M 12.2M 16.7M 17.6M
Long Term Deferred Expenses 1.7M 3.2M 2.6M 10.0M 21.2M 7.3M 16.7M 4.0M 15.2M 3.7M 7.6M 4.5M 905,000 2.9M
Total Non Current Assets 2.1B 1.9B 1.9B 1.8B 1.1B 308.0M 326.0M 302.0M 331.0M 349.0M 354.0M 290.0M 221.0M 153.0M
Total Assets 5.1B 4.5B 4.1B 3.8B 3.8B 3.4B 2.1B 1.6B 1.5B 1.4B 1.2B 939.0M 705.0M 597.0M
Short Term Borrowings 790.0M 100.0M 100.0M -- 107.0M -- -- -- 20.6M 15.6M -- -- -- --
Accounts Payable 359.0M 263.0M 230.0M 198.0M 253.0M 290.0M 273.0M -- -- 142.0M 164.0M 116.0M 76.5M 67.1M
Advance Receipts -- -- -- -- -- 163.0M 184.0M 205.0M 230.0M 298.0M 277.0M 279.0M 247.0M 209.0M
Contract Liabilities 195.0M 240.0M 94.5M 145.0M 228.0M -- -- -- -- -- -- -- -- --
Total Current Liabilities 1.6B 1.0B 668.0M 577.0M 787.0M 740.0M 709.0M 619.0M 635.0M 650.0M 597.0M 486.0M 470.0M 449.0M
Long Term Borrowings -- -- 148.0M -- -- -- -- -- -- -- -- -- -- --
Total Non Current Liabilities 19.5M 25.0M 173.0M 26.6M 7.8M 26.4M 25.6M 23.5M 13.1M -- -- -- -- --
Total Liabilities 1.6B 1.0B 842.0M 603.0M 794.0M 766.0M 735.0M 643.0M 648.0M 650.0M 597.0M 486.0M 470.0M 449.0M
Paid In Capital 401.0M 401.0M 401.0M 402.0M 401.0M 401.0M 360.0M 360.0M 360.0M 360.0M 180.0M 180.0M 80.0M 30.0M
Capital Reserve 761.0M 760.0M 774.0M 780.0M 754.0M 754.0M 15.7M 15.7M 15.7M 15.7M 15.7M 15.7M 15.7M 1.7M
Surplus Reserve 201.0M 201.0M 201.0M 201.0M 200.0M 196.0M 168.0M 131.0M 110.0M 92.8M 55.3M 34.3M 27.5M 18.0M
Retained Earnings 2.0B 2.0B 1.8B 1.7B 1.6B 1.3B 832.0M 453.0M 342.0M 247.0M 353.0M 223.0M 111.0M 97.9M
Minority Equity 66.1M 71.4M 64.5M 74.4M 22.9M -- 6.6M -- -- -- -- -- 380,700 400,000
Equity Attributable 3.4B 3.3B 3.2B 3.1B 3.0B 2.7B 1.4B 960.0M 828.0M 716.0M 604.0M 453.0M 234.0M 148.0M
Total Equity 3.4B 3.4B 3.3B 3.2B 3.0B 2.7B 1.4B 960.0M 828.0M 716.0M 604.0M 453.0M 235.0M 148.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013FY 2012Dec 31, 2012FY 2011Dec 31, 2011
Cash From Sales 2.7B 2.4B 1.7B 1.9B 1.9B 2.1B 1.9B 1.6B 1.3B 1.4B 1.3B 1.2B 997.0M 813.0M
Tax Refunds Received 263,100 419,200 108,300 2.4M 3.2M 287,100 32.6M -- 10.0M 16.6M 11.1M 11.7M 35.5M --
Total Operating Cash Inflow 2.8B 2.4B 1.8B 1.9B 2.0B 2.1B 2.0B 1.6B 1.4B 1.5B 1.3B 1.2B 1.0B 814.0M
Cash Paid For Goods 801.0M 672.0M 591.0M 747.0M 584.0M 613.0M 639.0M 561.0M 385.0M 516.0M 281.0M 248.0M 249.0M 162.0M
Cash Paid To Employees 233.0M 209.0M 209.0M 192.0M 131.0M 131.0M 120.0M 108.0M 100.0M 89.1M 72.8M 60.6M 48.2M 24.4M
Taxes Paid 257.0M 239.0M 263.0M 253.0M 232.0M 271.0M 220.0M 217.0M 184.0M 207.0M 165.0M 165.0M 177.0M 134.0M
Total Operating Cash Outflow 2.5B 2.1B 1.7B 1.9B 1.6B 1.7B 1.4B 1.3B 1.1B 1.2B 917.0M 897.0M 813.0M 545.0M
Operating Cash Flow 301.0M 338.0M 48.4M -7.5M 362.0M 466.0M 517.0M 356.0M 213.0M 260.0M 376.0M 326.0M 227.0M 269.0M
Total Investing Cash Inflow 1.4B 570.0M 829.0M 2.2B 3.2B 1.4B 1.1B 582.0M 2,100 53,500 1,736 -- 773,100 822.0M
Total Investing Cash Outflow 968.0M 785.0M 759.0M 2.9B 4.0B 2.1B 1.2B 576.0M 6.6M 12.1M 44.6M 67.1M 105.0M 946.0M
Investing Cash Flow 432.0M -215.0M 70.1M -681.0M -782.0M -699.0M -56.2M 6.0M -6.6M -12.0M -44.6M -67.1M -104.0M -124.0M
Cash From Borrowings 150.0M 100.0M 150.0M -- 107.0M -- -- 11.9M 41.2M 26.6M -- -- -- --
Dividends And Interest Paid 314.0M 111.0M 76.8M 142.0M 157.0M -- -- 180.0M 120.0M 170.0M 120.0M 100.0M 100.0M --
Debt Repayments 248.0M 2.0M -- 107.0M -- -- -- 32.5M 36.2M 11.1M -- -- -- --
Total Financing Cash Inflow 787.0M 100.0M 249.0M 90.0M 132.0M 842.0M -- 11.9M 41.2M 26.6M -- -- -- 400,000
Total Financing Cash Outflow 980.0M 246.0M 104.0M 260.0M 157.0M 70.2M -- 212.0M 156.0M 181.0M 120.0M 100.0M 100.0M 100,000
Financing Cash Flow -193.0M -145.0M 145.0M -170.0M -24.8M 772.0M -- -201.0M -115.0M -154.0M -120.0M -100.0M -100.0M 300,000
Net Change In Cash 540.0M -22.4M 263.0M -858.0M -445.0M 538.0M 460.0M 162.0M 91.6M 93.1M 212.0M 158.0M 23.4M 146.0M
Ending Cash Balance 1.6B 1.0B 1.1B 799.0M 1.7B 2.1B 1.6B 1.1B 941.0M 850.0M 757.0M 545.0M 387.0M 364.0M
Capex 316.0M 254.0M 111.0M 117.0M 749.0M 6.4M 11.3M 6.4M 6.6M 12.1M 44.6M 67.1M 79.3M 126.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...